Oncology – Brain
M-A: Stereotactic radiosurgery vs. whole brain radiotherapy in patients with intracranial metastatic disease and small-cell lung cancer.
30 May, 2022 | 10:41h | UTCStereotactic radiosurgery versus whole brain radiotherapy in patients with intracranial metastatic disease and small-cell lung cancer: a systematic review and meta-analysis – The Lancet Oncology (link to abstract – $ for full-text)
Cohort Study: Effect of awake craniotomy in glioblastoma in eloquent areas.
23 May, 2022 | 00:40h | UTCEffect of awake craniotomy in glioblastoma in eloquent areas (GLIOMAP): a propensity score-matched analysis of an international, multicentre, cohort study – the Lancet Oncology (link to abstract – $ for full-text)
Commentary: Neurologic and Survival Outcomes After Awake Craniotomy for Glioblastoma – The ASCO Post
Commentary on Twitter
In matched cohort of patients with glioblastoma, awake craniotomy resulted in fewer neurological deficits at 3 mo and 6 mo post-surgery than asleep resection, and longer mOS (17.0 mo versus 14.0 mo; P =0.0005), and mPFS (9.0 mo versus 7.3 mo; P = 0.006) https://t.co/S1fdRTxYDg
— NatureRevClinOncol (@NatRevClinOncol) May 19, 2022
RCT: Treatment with Etirinotecan pegol for patients with metastatic breast cancer and brain metastases.
13 May, 2022 | 10:51h | UTCTreatment With Etirinotecan Pegol for Patients With Metastatic Breast Cancer and Brain Metastases: Final Results From the Phase 3 ATTAIN Randomized Clinical Trial – JAMA Oncology (free for a limited period)
Commentary on Twitter
Treatment with etirinotecan pegol showed no statistically significant improvement in survival among patients with #BreastCancer & brain metastases, but study represents larged published study for this understudied population. https://t.co/AVKeo1BWQV #BCSM #BTSM
— JAMA Oncology (@JAMAOnc) May 12, 2022
ASTRO Guideline: Radiation therapy for brain metastases.
12 May, 2022 | 10:11h | UTCNews Release: ASTRO issues clinical guideline on radiation therapy for brain metastases – American Society for Radiation Oncology
Commentary on Twitter
ASTRO has released a guideline on #RadiationTherapy for brain metastases, which updates the original 2012 guideline. The publication in #PracticalRO includes treatment algorithms for limited & extensive brain metastases. Read here: https://t.co/5QRI0XqWHx #RadOnc pic.twitter.com/oNj2nzAKdm
— ASTRO (@ASTRO_org) May 10, 2022
Study finds no increased risk of brain tumors for mobile phone users.
1 Apr, 2022 | 10:04h | UTCNews Release: No increased risk of brain tumours for mobile phone users, new study finds – University of Oxford
Original Study: Cellular Telephone Use and the Risk of Brain Tumors: Update of the UK Million Women Study – JNCI: Journal of the National Cancer Institute
SEOM-GEINO clinical guideline of systemic therapy and management of brain central nervous system metastases.
18 Mar, 2022 | 08:14h | UTC
Same-day discharge after brain tumor resection: a prospective pilot study.
9 Mar, 2022 | 08:19h | UTC
Commentary on Twitter
In select patients, same day discharge after #brainsurgery can be safe and effective, leading to improved patient feeling of wellness and satisfaction. #brain #cancer #costs @NSTumorSection https://t.co/TSGXcx9dmn pic.twitter.com/VVxuSiGTUX
— Journal of Neuro-Oncology (@JNeurooncol) March 2, 2022
Systematic Review: Diagnostic test accuracy and cost‐effectiveness of tests for codeletion of chromosomal arms 1p and 19q in people with glioma.
8 Mar, 2022 | 08:24h | UTC
ASCO-SNO Guideline: Therapy for diffuse astrocytic and oligodendroglial tumors in adults.
26 Jan, 2022 | 01:19h | UTC
Treatment for Brain Metastases: ASCO-SNO-ASTRO Guideline.
21 Jan, 2022 | 09:36h | UTCTreatment for Brain Metastases: ASCO-SNO-ASTRO Guideline – Journal of Clinical Oncology
Long-term outcomes of patients with active melanoma brain metastases treated with combination nivolumab plus ipilimumab.
16 Nov, 2021 | 08:14h | UTCLong-term outcomes of patients with active melanoma brain metastases treated with combination nivolumab plus ipilimumab (CheckMate 204): final results of an open-label, multicentre, phase 2 study – The Lancet Oncology (link to abstract – $ for full-text)
Original Study: Study: Combination Immunotherapy for Melanoma Brain Metastases
M-A: Treatment options for progression or recurrence of glioblastoma.
26 Sep, 2021 | 21:34h | UTCSummary: Treatment options for people with recurrent and progressive glioblastoma – Cochrane Library
Brain and other central nervous system tumor statistics, 2021 – There were few improvements in the care of Glioblastoma in the past 4 decades. Specifically, the 5-year survival only increased from 4% to 7%.
1 Sep, 2021 | 08:58h | UTCBrain and other central nervous system tumor statistics, 2021 – CA: A Cancer Journal for Clinicians
Randomized phase III trial of prophylactic cranial irradiation with or without hippocampal avoidance for small-cell lung cancer – “This trial provides the first clinical evidence that sparing the hippocampus during PCI in patients with SCLC better preserves cognitive function”.
13 Aug, 2021 | 08:54h | UTC
EANO–ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with brain metastasis from solid tumors.
11 Aug, 2021 | 08:29h | UTCCommentary: New guidelines for the diagnosis and treatment of brain metastases – University of Vienna
Commentary on Twitter
Just out📣 @EANOassociation-ESMO Guidelines for the management of patients with #brain metastasis from solid #tumours: find out the latest recommendations, immunohistochemical markers for #carcinoma of unknown primary and treatment algorithms 🔎 https://t.co/CriaZKxFJr #btsm pic.twitter.com/0yQqmJMzT1
— ESMO – Eur. Oncology (@myESMO) August 5, 2021
Diagnosing and treating brain tumors: reflections on the latest Cochrane evidence
19 Mar, 2021 | 08:06h | UTC
Guidelines in the management of CNS tumors
23 Feb, 2021 | 01:09h | UTCGuidelines in the management of CNS tumors – Journal of Neuro-Oncology
Intraoperative imaging technology to maximize extent of resection for glioma: a network meta‐analysis
8 Feb, 2021 | 20:11h | UTC